Company News
Watchdog leans towards blocking Sainsbury-Asda merger
The UK competition watchdog has "extensive" concerns over the proposed £13bn merger between Sainsbury's and Asda, warning of the potential for pushing up prices and reducing ranges in hundreds of local areas.
US carrier Mesa involved in fresh bid for Flybe
US-based regional airline Mesa Air Group is involved a bid to save struggling British carrier Flybe, it was revealed on Wednesday morning.
Glencore to cap coal production as full year earnings rise
Glencore said full year adjusted earnings increased 8% to $15. 8bn as it announced plans for a $2bn share buyback and a cap on coal production in response to pressure for action on climate change.
Intu earnings fall after tough year
Intu Properties reported a fall in earnings in its audited results for 2018 on Wednesday, with the underlying figure dropping to £193. 1m from £201m in the prior year.
Gooch & Housego shares tank as demand declines
Photonics manufacturer Gooch & Housego warned investors on Tuesday that it had seen a downturn in demand for its products in the first four months of its trading year.
Lower silver prices take the shine off Hochschild
Full year profits at Hochschild Mining slumped as declining silver prices took the shine off above-forecast production.
Castleton Technologies acquires Indian business
Software and services provider Castleton Technology has snapped up the firm previously known as CarbonNV InfoLogic India for a total consideration of £350,000.
IMImobile names Bruce Bales as North American CEO
Cloud communications software provider IMImobile appointed industry veteran Bruce Bales to take on the role of North American chief executive on Wednesday.
Tritax completes investment in massive db Symmetry portfolio
Tritax Big Box REIT has completed the acquisition of an 87% interest in db Symmetry, it confirmed on Wednesday, on the terms it set out on 25 January.
CLS buys Aldgate property for £53.9m
CLS Holdings has exchanged contracts to acquire 9 Prescot Street, London E1 for £53. 85m excluding costs, it announced on Wednesday.
Indivior to release generic version of opioid drug after losing court battle
Indivior said it was releasing an authorised generic version of its Suboxone opiod addiction treatment in the US after losing a court bid to stop a copycat version made by India-based rival Dr. Reddy’s Laboratories.